Skip to main content
TipRanks
Go Ultimate75% OFF

Navicare Biotech Co., Ltd. (8472) Balance Sheet

Navicare Biotech Co., Ltd. Balance Sheet

Navicare Biotech Co., Ltd.'s total assets for Q2 2026 were NT$994.20M, a decrease of 4.71% from the previous quarter. TW:8472 total liabilities were NT$735.35M for the fiscal quarter, a 5.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Mar 23Dec 21
NT$ 1.05BNT$ 999.54MNT$ 1.18BNT$ 1.21BNT$ 1.05B
NT$ 779.12MNT$ 714.47MNT$ 818.89MNT$ 796.38MNT$ 521.48M
NT$ 270.50MNT$ 285.07MNT$ 363.53MNT$ 415.36MNT$ 527.27M

Currency in TWD

Navicare Biotech Co., Ltd. Liabilities to Assets

0500M1B1.5B48 %60 %72 %84 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets